Details for New Drug Application (NDA): 083450
✉ Email this page to a colleague
NDA 083450 describes S.A.S.-500, which is a drug marketed by Solvay and is included in one NDA. Additional details are available on the S.A.S.-500 profile page.
The generic ingredient in S.A.S.-500 is sulfasalazine. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
The generic ingredient in S.A.S.-500 is sulfasalazine. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
Summary for 083450
| Tradename: | S.A.S.-500 |
| Applicant: | Solvay |
| Ingredient: | sulfasalazine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083450
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
